EMA Recommends 2026-27 COVID Vaccines Should Target XFG Variant

Reuters (5/29, Das) reported the European Medicines Agency “said on Friday COVID-19 vaccines for the 2026-27 vaccination campaign ​in Europe should preferably be updated to target the XFG variant. The decision aligns with the U.S. FDA’s advisory panel, which on Thursday voted in favor of the same target for next season’s ​shots.” According to Reuters, EMA “said XFG is the preferred choice within the current Omicron-related variant family, though closely related variants such as LP.8.1 ​could also be considered.”